Benzinga | Nov 15, 2021 11:11AM EST

Evercore ISI Group Initiates Coverage On Ventyx Biosciences with Outperform Rating, Announces Price Target of $50

Evercore ISI Group analyst Josh Schimmer initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Outperform rating and announces Price Target of $50.